Corteva (NYSE:CTVA) Sees Unusually-High Trading Volume - Should You Buy?

Corteva, Inc. (NYSE:CTVA - Get Free Report) saw strong trading volume on Thursday. Approximately 15,566,366 shares traded hands during trading, an increase of 144% from the previous session's volume of 6,389,680 shares. The stock last traded at $14.1220 and had previously closed at $14.45.

Trending Headlines about Corteva

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: KeyBanc upgraded Corteva to Overweight and set a $17 price target, arguing that the post-spinoff company could achieve meaningful earnings growth after 2027 as it becomes more focused. Corteva upgraded at KeyBanc after spinoff of Vylor
• Positive Sentiment: J.P. Morgan also upgraded Corteva after the Vylor separation, describing the stock as undervalued and seeing substantial potential upside. The upgrades helped drive a sharp rally earlier in the week. Corteva Soars on JPMorgan Upgrade
• Positive Sentiment: Investors bought 5,408 CTVA call options, more than five times typical daily call volume, suggesting increased speculative bullish interest in the shares.
• Neutral Sentiment: KeyCorp maintained an Overweight rating and a $17 price objective, but its FY2029 EPS estimate of $1.60 is well below the current-year consensus estimate of $2.77, highlighting uncertainty over the company’s longer-term earnings trajectory.
• Neutral Sentiment: Jim Cramer said he preferred building a position in Vylor, the spun-off seed business, while remaining cautious on Corteva’s crop-protection operations. Jim Cramer on Corteva’s Breakup
• Negative Sentiment: Zacks Research downgraded CTVA from “Hold” to “Strong Sell,” creating a significant counterweight to the recent upgrades and likely contributing to the stock’s weaker performance.

Wall Street Analyst Weigh In

CTVA has been the subject of a number of research reports. Bank of America lifted their price target on Corteva from $90.00 to $96.00 and gave the stock a "buy" rating in a research report on Monday, July 20th. Deutsche Bank Aktiengesellschaft restated a "buy" rating and issued a $101.00 price objective on shares of Corteva in a research note on Monday, August 3rd. New Street Research set a $17.00 target price on Corteva in a research report on Monday. Zacks Research lowered shares of Corteva from a "hold" rating to a "strong sell" rating in a research report on Tuesday. Finally, KeyCorp upgraded shares of Corteva from a "sector weight" rating to an "overweight" rating and set a $17.00 price objective for the company in a research note on Wednesday. Sixteen investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $64.00.

Corteva Stock Down 1.6%

The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.10 and a current ratio of 1.52. The firm has a market capitalization of $9.48 billion, a price-to-earnings ratio of 9.41, a P/E/G ratio of 0.73 and a beta of 0.57. The business has a 50 day simple moving average of $74.30 and a 200-day simple moving average of $79.19.

Corteva (NYSE:CTVA - Get Free Report) last posted its quarterly earnings data on Thursday, July 30th. The company reported $2.30 earnings per share for the quarter, topping analysts' consensus estimates of $2.24 by $0.06. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The firm had revenue of $6.38 billion during the quarter, compared to analysts' expectations of $6.60 billion. During the same quarter last year, the company posted $2.20 EPS. The firm's quarterly revenue was down 1.2% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, equities analysts expect that Corteva, Inc. will post 2.77 EPS for the current year.

Corteva Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st were issued a $0.18 dividend. The ex-dividend date of this dividend was Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 5.1%. Corteva's payout ratio is presently 47.68%.

Hedge Funds Weigh In On Corteva

Several hedge funds have recently bought and sold shares of CTVA. BlackRock Inc. bought a new position in Corteva during the 2nd quarter valued at $4,560,180,000. Wellington Management Group LLP increased its stake in shares of Corteva by 941.7% during the second quarter. Wellington Management Group LLP now owns 7,612,704 shares of the company's stock valued at $644,720,000 after acquiring an additional 6,881,875 shares during the period. Jupiter Topco LLC acquired a new position in Corteva during the second quarter worth about $544,246,000. Bank of America Corp DE bought a new stake in Corteva during the second quarter worth approximately $484,927,000. Finally, Legal & General Group Plc acquired a new position in shares of Corteva in the 2nd quarter worth $482,836,000. Hedge funds and other institutional investors own 81.54% of the company's stock.

About Corteva

Corteva, Inc is an agriculture-focused company that develops and supplies seed, crop protection and digital agriculture products. Its offerings are designed to help farmers improve crop productivity, manage pests and diseases, and support more efficient and sustainable farming practices.

The company's seed portfolio includes corn, soybean, wheat, sunflower, canola, cotton and other crops, marketed through brands such as Pioneer, Brevant seeds and PhytoGen. Corteva also provides herbicides, insecticides, fungicides, biological products and seed treatments under a range of agricultural brands.

Corteva serves farmers, agricultural retailers and other customers in markets around the world.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.